Gara Jalqabaatti › Saree (Gosoota Hunda) › Texas › Irving
Qorannoo klinikaalii Saree (Gosoota Hunda) Irving, TX keessatti
Qorannoo 15 Saree (Gosoota Hunda) f Irving fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
REC-7735 in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology - Dallas, Irving
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Dallas, Irving
Registry Study for Radiation Therapy Outcomes
Namoota walitti qabaa jiraQorannoo ilaalaa
- Texas Center for Proton Therapy, Irving
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Namoota walitti qabaa jiraSadarkaa 3
- US Oncology Research Investigational Products Center, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Dallas, Irving
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology ( Site 0051), Irving
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology ( Site 1012), Irving
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology Dallas, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology Dallas, Irving
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Dallas, Irving
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Dallas, Irving
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology, Irving
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Dallas, Irving
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
Namoota walitti qabaa jiraQorannoo ilaalaa
- Texas Center for Proton Therapy, Irving
Qorannoo Saree (Gosoota Hunda) magaalota biroo keessatti
- Houston, TXQorannoo 121
- New York City, NYQorannoo 110
- Boston, MAQorannoo 86
- Los Angeles, CAQorannoo 73
- Nashville, TNQorannoo 65
- Philadelphia, PAQorannoo 59
- Durham, NCQorannoo 58
- Washington, DCQorannoo 58
- Chicago, ILQorannoo 51
- Seattle, WAQorannoo 49
- Atlanta, GAQorannoo 49
- Arlington, VAQorannoo 48
Qorannoo biroo Irving keessatti
- Kansara Qara'a Non-Small CellQorannoo 22
- Kansarii ColorectalQorannoo 13
- Kansara MetastatikiiQorannoo 11
- Kansarii PancreasQorannoo 7
- Kanisa HarkaaQorannoo 7
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 6
- Saree OljooQorannoo 6
- Kansarii Hafuu Seli XiqqaaQorannoo 6
- Dhibee QaraQorannoo 6
- Kansarii OvariiQorannoo 5
- Kansa EndometiriyaaliiQorannoo 4
- Kansarii ProstateQorannoo 4
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.